Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀÓÇöõÆ®ÁÖÀ§ÁúȯÀÇ À¯º´À², Áø´Ü, Ä¡·á ±×¸®°í ÇÑ°è

Peri-implant diseases: prevalence, diagnosis, treatment and limitations

´ëÇÑÄ¡°úÀÇ»çÇùȸÁö 2022³â 60±Ç 8È£ p.496 ~ 502
ÁÖÁö¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÁÖÁö¿µ ( Joo Ji-Young ) - Pusan National University School of Dentistry Department of Periodontology

Abstract


Peri-implant diseases are prevalent with a weighted mean prevalence rate of 43% across Europe and 22% across South and North America. Although the main etiologic agent is bacterial biofilm, various factors influence the initiation and progression of the disease. Unfortunately, the treatment of peri-implant diseases is at best favorable in the short term with a high rate of persistent inflammation and recurrence. Therefore, it is sensible to consider and control all potential factors that may predispose an implant to peri-implant tissue inflammation in an attempt to avoid the disease. If periodic maintenance treatment is not performed, there is a high probability of recurrence of the disease and can lead to the loss of the implant.

Å°¿öµå

Peri-implant diseases; Peri-implantitis; Peri-implant mucositis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI